Literature DB >> 33715111

Lung Edema and Mortality Induced by Intestinal Ischemia and Reperfusion Is Regulated by VAChT Levels in Female Mice.

Fernanda P R Santana1, Fernanda Y Ricardo-da-Silva2, Evelyn T Fantozzi3, Nathália M Pinheiro4,5, Iolanda F L C Tibério5, Luiz Felipe Pinho Moreira2, Marco Antônio M Prado6,7, Vânia F Prado6,7, Wothan Tavares-de-Lima3, Carla Máximo Prado8,9,10, Ana Cristina Breithaupt-Faloppa2.   

Abstract

Acute lung injury induced by intestinal ischemia/reperfusion (I/R) is a relevant clinical condition. Acetylcholine (ACh) and the α7 nicotinic ACh receptor (nAChRα-7) are involved in the control of inflammation. Mice with reduced levels of the vesicular ACh transporter (VAChT), a protein responsible for controlling ACh release, were used to test the involvement of cholinergic signaling in lung inflammation due to intestinal I/R. Female mice with reduced levels of VAChT (VAChT-KDHOM) or wild-type littermate controls (WT) were submitted to intestinal I/R followed by 2 h of reperfusion. Mortality, vascular permeability, and recruitment of inflammatory cells into the lung were investigated. Parts of mice were submitted to ovariectomy (OVx) to study the effect of sex hormones or treated with PNU-282,987 (nAChRα-7 agonist). A total of 43.4% of VAChT-KDHOM-I/R mice died in the reperfusion period compared to 5.2% of WT I/R mice. The I/R increased lung inflammation in both genotypes. In VAChT-KDHOM mice, I/R increased vascular permeability and decreased the release of cytokines in the lung compared to WT I/R mice. Ovariectomy reduced lung inflammation and permeability compared to non-OVx, but it did not avoid mortality in VAChT-KDHOM-I/R mice. PNU treatment reduced lung permeability, increased the release of proinflammatory cytokines and the myeloperoxidase activity in the lungs, and prevented the increased mortality observed in VAChT-KDHOM mice. Cholinergic signaling is an important component of the lung protector response against intestinal I/R injury. Decreased cholinergic signaling seems to increase pulmonary edema and dysfunctional cytokine release that increased mortality, which can be prevented by increasing activation of nAChRα-7.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  PNU-282,987; acetylcholine; acute lung injury; cholinergic anti-inflammatory pathway; experimental model; intestinal ischemia and reperfusion

Mesh:

Substances:

Year:  2021        PMID: 33715111     DOI: 10.1007/s10753-021-01440-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

1.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 2.  Acute mesenteric ischemia: a clinical review.

Authors:  W Andrew Oldenburg; L Louis Lau; Thomas J Rodenberg; Hope J Edmonds; Charles D Burger
Journal:  Arch Intern Med       Date:  2004-05-24

3.  The vesicular acetylcholine transporter is required for neuromuscular development and function.

Authors:  Braulio M de Castro; Xavier De Jaeger; Cristina Martins-Silva; Ricardo D F Lima; Ernani Amaral; Cristiane Menezes; Patricia Lima; Cintia M L Neves; Rita G Pires; Thomas W Gould; Ian Welch; Christopher Kushmerick; Cristina Guatimosim; Ivan Izquierdo; Martin Cammarota; R Jane Rylett; Marcus V Gomez; Marc G Caron; Ronald W Oppenheim; Marco A M Prado; Vania F Prado
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

4.  Estradiol mediates the long-lasting lung inflammation induced by intestinal ischemia and reperfusion.

Authors:  Evelyn Thais Fantozzi; Ana Cristina Breithaupt-Faloppa; Fernanda Yamamoto Ricardo-da-Silva; Sara Rodrigues-Garbin; Daniel Cancelli Romero; Adriana da Silva Rodrigues; Yanira Riffo-Vasquez; Wothan Tavares-de-Lima
Journal:  J Surg Res       Date:  2018-01       Impact factor: 2.192

5.  IL-17A Produced by Innate Lymphoid Cells Is Essential for Intestinal Ischemia-Reperfusion Injury.

Authors:  Mayya Geha; Maria G Tsokos; Robin E Bosse; Tatyana Sannikova; Yoichiro Iwakura; Jurandir J Dalle Lucca; Rene De Waal Malefyt; George C Tsokos
Journal:  J Immunol       Date:  2017-09-06       Impact factor: 5.422

6.  Lymphatic system as a path underlying the spread of lung and gut injury after intestinal ischemia/reperfusion in rats.

Authors:  Gabriela Cavriani; Helori Vanni Domingos; Alexandre Learth Soares; Aryene Goes Trezena; Ana Paula Ligeiro-Oliveira; Ricardo Martins Oliveira-Filho; Lia Siguemi Sudo-Hayashi; Wothan Tavares de Lima
Journal:  Shock       Date:  2005-04       Impact factor: 3.454

7.  Down-regulation of the non-neuronal acetylcholine synthesis and release machinery in acute allergic airway inflammation of rat and mouse.

Authors:  Katrin S Lips; Anke Lührmann; Thomas Tschernig; Tobias Stoeger; Francesca Alessandrini; Veronika Grau; Rainer V Haberberger; Hermann Koepsell; Reinhard Pabst; Wolfgang Kummer
Journal:  Life Sci       Date:  2007-01-23       Impact factor: 5.037

Review 8.  Acute intestinal ischemia and infarction.

Authors:  David A Tendler
Journal:  Semin Gastrointest Dis       Date:  2003-04

Review 9.  New approaches to the study of sepsis.

Authors:  Peter A Ward
Journal:  EMBO Mol Med       Date:  2012-12       Impact factor: 12.137

10.  Protective Effects of Anti-IL17 on Acute Lung Injury Induced by LPS in Mice.

Authors:  Renato Fraga Righetti; Tabata Maruyama Dos Santos; Leandro do Nascimento Camargo; Luciana Ritha Cássia Rolim Barbosa Aristóteles; Silvia Fukuzaki; Flávia Castro Ribas de Souza; Fernanda Paula Roncon Santana; Marcus Vinicius Rodrigues de Agrela; Maysa Mariana Cruz; Maria Isabel Cardoso Alonso-Vale; Isabella Santos Genaro; Beatriz Mangueira Saraiva-Romanholo; Edna Aparecida Leick; Milton de Arruda Martins; Carla Máximo Prado; Iolanda de Fátima Lopes Calvo Tibério
Journal:  Front Pharmacol       Date:  2018-10-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.